BioInfra Co., Ltd. (KOSDAQ:199730)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,785.00
+100.00 (2.13%)
At close: Dec 5, 2025
-24.88%
Market Cap23.49B
Revenue (ttm)21.92B
Net Income (ttm)-5.63B
Shares Out4.86M
EPS (ttm)-1,157.12
PE Ration/a
Forward PEn/a
Dividend400.00 (8.36%)
Ex-Dividend DateDec 29, 2025
Volume7,037
Average Volume15,321
Open4,695.00
Previous Close4,685.00
Day's Range4,675.00 - 4,815.00
52-Week Range4,535.00 - 7,620.00
Beta0.67
RSI57.21
Earnings Daten/a

About BioInfra

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. Its primary product is a bioequivalence test for generic drugs, a phase 1 test for incrementally modified drugs; and a phase 1 sample analysis for other new substances. The company was founded in 2007 and is based in Yongin-si, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2007
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 199730
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.